A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

December 9, 2021

Study Completion Date

December 9, 2021

Conditions
Primary Hypertension
Interventions
OTHER

Heat-sensitive moxibustion plus original antihypertensive treatment (compulsively randomized arm)

In this group, patients will self-administer heat-sensitive moxibustion or have family members help with the administration for six months. During this period, they will maintain their original antihypertensive treatment.

DRUG

Original antihypertensive treatment (compulsively randomized arm)

In this group, patients will maintain their original antihypertensive treatment.

OTHER

Heat-sensitive moxibustion plus antihypertensive treatment (voluntarily randomized arm)

In this group, patients will self-administer heat-sensitive moxibustion or have family members help with the administration for six months. During this period, they will maintain their original antihypertensive treatment.

DRUG

Original antihypertensive treatment (voluntarily randomized arm)

In this group, patients will maintain their original antihypertensive treatment.

OTHER

Heat-sensitive moxibustion plus original antihypertensive treatment (preference selection arm)

In this group, patients will self-administer heat-sensitive moxibustion or have family members help with the administration for six months. During this period, they will maintain their original antihypertensive treatment.

DRUG

Original antihypertensive treatment (preference selection arm)

In this group, patients will maintain their original antihypertensive treatment.

Trial Locations (7)

330004

Erliuling, Nanchang

Hongmiao, Nanchang

Jinghexinggong community, Nanchang

Jinsheng community, Nanchang

Nangang community, Nanchang

Shajing, Nanchang

Wuliangdian community, Nanchang

All Listed Sponsors
lead

Jiangxi University of Traditional Chinese Medicine

OTHER

NCT04788563 - A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community | Biotech Hunter | Biotech Hunter